TIMP4 and chronic obstructive pulmonary disease: However, there were no significant differences in TIMP-4 and NE mRNA expression levels between different severity of airflow limitation in COPD patients (P = 0.74, Figure 5(b) and P = 0.63, Figure 5(c)).